Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial

Journal article

Open access

R. Dimitrova, H. Kim, J. Meilahn, H. G. Chambers, B. A. Racette, M. Bonikowski, E. S. Park, E. McCusker, C. Liu and M. F. Brin

NeuroRehabilitation, Vol.50(1)

2022

Files and links (1)

url

https://doi.org/10.3233/NRE-210070View

Published (Version of record) Open

1 Record Views

Title: Efficacy and safety of onabotulinumtoxinA with standardized physiotherapy for the treatment of pediatric lower limb spasticity: A randomized, placebo-controlled, phase III clinical trial
Creators: R. Dimitrova - AbbVie
H. Kim - Columbia University Irving Medical Center
J. Meilahn - Marshfield Clinic
H. G. Chambers - Rady Children's Hospital-San Diego
B. A. Racette - Washington University in St. Louis
M. Bonikowski
E. S. Park - Yonsei University
E. McCusker - AbbVie
C. Liu - Allergan
M. F. Brin - AbbVie
Publication Details: NeuroRehabilitation, Vol.50(1)
Identifiers: 991006034854102656
Academic Unit: Neurology
Resource Type: Journal article